Literature DB >> 8297172

Human gallstones contain pronucleating nonmucin glycoproteins that are immunoglobulins.

P A Lipsett1, J Hildreth, H S Kaufman, K D Lillemoe, H A Pitt.   

Abstract

OBJECTIVE: Pronucleating nonmucin glycoproteins in human cholesterol and black gallstones were isolated and identified. SUMMARY BACKGROUND DATA: Gallbladder bile contains nonmucin glycoproteins that are pronucleating of cholesterol monohydrate crystals. Little is known about the presence or activity of these proteins within gallstones.
METHODS: Nonmucin glycoproteins were isolated from single cholesterol (n = 8), multiple cholesterol (n = 8), and black pigment (n = 8) gallstones by concanavalin A lectin-affinity chromatography. The proteins were separated by sodium dodecyl sulfate gradient electrophoresis. Western blot analysis was performed for Fab immunoglobulin fragments, and heavy chains from the immunoglobulin G, A, E, and M subclasses. A crystal observation time assay was performed on the combination of isolated nonmucin glycoproteins from gallstones and isolated Fab fragments.
RESULTS: Nonmucin glycoproteins of molecular weights 10, 15, 17, 22, 28, and 208 kD were identified in gallstones. These six nonmucin glycoproteins shortened the crystal observation time by more than 50% (p < 0.01) compared with model bile. Western blot analysis confirmed the identity of the 22- and 28-kD proteins as immunoglobulin Fab fragments. These were seen in all gallstones, irrespective of the gallstone type. The isolated Fab 28-kD fragment from the gallstones of 23 patients shortened the extrapolated crystal observation time by 78% (p < 0.01). However, commercially available Fab fragments had no effect on either cholesterol crystal appearance or growth.
CONCLUSIONS: Nonmucin glycoproteins that are pronucleating for cholesterol monohydrate crystals are also found in human cholesterol and black pigment gallstones. Fab immunoglobulin fragments were found in all gallstones irrespective of the gallstone type. Fab immunoglobulin fragments from gallstones shortened the crystal observation time but not crystal growth or total crystal content compared with model bile or commercially available Fab fragments. These data suggest that an antigen-immune (Fab) complex may contribute to cholesterol crystal function.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8297172      PMCID: PMC1243086          DOI: 10.1097/00000658-199401000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  23 in total

Review 1.  Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr and Randall.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1979-12       Impact factor: 3.365

2.  On the electrotransfer of polypeptides from gels to nitrocellulose membranes.

Authors:  W Lin; H Kasamatsu
Journal:  Anal Biochem       Date:  1983-02-01       Impact factor: 3.365

3.  Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile.

Authors:  A Kibe; R T Holzbach; N F LaRusso; S J Mao
Journal:  Science       Date:  1984-08-03       Impact factor: 47.728

4.  Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile.

Authors:  P F Levy; B F Smith; J T LaMont
Journal:  Gastroenterology       Date:  1984-08       Impact factor: 22.682

5.  Effect of mucous glycoprotein on nucleation time of human bile.

Authors:  S Gallinger; R D Taylor; P R Harvey; C N Petrunka; S M Strasberg
Journal:  Gastroenterology       Date:  1985-09       Impact factor: 22.682

6.  Lack of glucagon receptors in Morris hepatoma 7800.

Authors:  M Mourelle; M Rojkind
Journal:  Hepatology       Date:  1984 May-Jun       Impact factor: 17.425

7.  Biliary proteins. Unique inhibitors of cholesterol crystal nucleation in human gallbladder bile.

Authors:  R T Holzbach; A Kibe; E Thiel; J H Howell; M Marsh; R E Hermann
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

8.  Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man.

Authors:  R T Holzbach; M Marsh; M Olszewski; K Holan
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

9.  Isolation and characterization of a cholesterol crystallization promoter from human bile.

Authors:  M Abei; P Kawczak; H Nuutinen; A Langnas; J Svanvik; R T Holzbach
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

10.  Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease.

Authors:  K R Holan; R T Holzbach; R E Hermann; A M Cooperman; W J Claffey
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

View more
  4 in total

Review 1.  Cholesterol crystallisation in bile.

Authors:  P Portincasa; K J van Erpecum; G P Vanberge-Henegouwen
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

2.  Cholesterol crystal binding of biliary immunoglobulin A: visualization by fluorescence light microscopy.

Authors:  F Lammert; S Südfeld; N Busch; S Matern
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

3.  Elevated biliary calmodulin during gallstone formation: the role of bile acids.

Authors:  A J Moser; J A Karam; D I Giurgiu; P A Weber; Z R Abedin; J J Roslyn; M Z Abedin
Journal:  Dig Dis Sci       Date:  1998-01       Impact factor: 3.199

Review 4.  Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.

Authors:  Kirk J Maurer; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2008-12-25       Impact factor: 22.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.